RecruitingAlzheimer Disease or Associated DisorderDementiaCognitive Decline
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
Eligible age
60+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare services. he main question it aims to answer is: Do D2D rideshare services reduce missed medical appointment rates compared to C2C rideshare services?
Sponsor: Onward Health, Inc
You may qualify if…
- ✓ All participants (or their surrogate) have the capacity to agree to allow Onward service for transportation;
- ✓ have scheduled medical appointments at partner practices of Onward;
- ✓ ages 60+
- ✓ community-dwelling;
- ✓ 60 participants who self-reported cognitive problems, such as memory issue, or have mild cognitive impairment, subjective cognitive decline, or AD/ADRD diagnosis
- ✓ Resides and attends appointments in the following San Francisco Bay Area Counties (San Francisco, Alameda, Contra Costa, Marin, San Mateo, Sonoma)
You may not qualify if…
- ✕ current enrollment in another transportation study;
- ✕ already using any type of free or heavily subsized transportation service;
- ✕ enrollees with comfort care only;
- ✕ Not wheelchair bound, e.g. if using a wheelchair must be foldable and must be able to transfer
- ✕ Transient, lacking consistent long term housing
- ✕ Resides outside of the San Francisco Bay Area
Where it's recruiting
California
San Leandro
Source: ClinicalTrials.gov · NCT06850870 · last updated 2025-11-25